Lactobacillus acidophilus La5 3777 06a J

Lactobacillus acidophilus (LA-5®)

Facts about Lactobacillus acidophilus (LA-5®)

  • Identified as Lactobacillus acidophilus

  • Strain deposit number: DSM13241

  • Originates from Chr. Hansen’s collection of dairy cultures

  • LA-5® is a registered trademark of Chr. Hansen A/S

  • Used worldwide since 1979 as an ingredient in food and dietary supplements, with no reported consumer illness or injury

  • Tested in clinical studies in dosages up to at least 50 billion CFU/day, with no reported serious adverse events

Well-documented probiotic Lactobacillus strain

Used in food and dietary supplements since 1979, described in more than 1501 scientific publications and tested in more than 601 clinical studies, Lactobacillus (LA-5®) is a well-characterized and well-documented probiotic strain.

In Europe, Lactobacillus acidophilus has been granted Qualified Presumption of Safety (QPS) status since 2007 by the European Food Safety Authority (EFSA) – a status granted on species level. The US Food and Drug Administration (FDA) has designated the LA-5® strain as Generally Recognized As Safe (GRAS).

Clinical studies

The combination of the LA-5® and BB-12® probiotic strains gives you the opportunity to have both Lactobacillus and Bifidobacterium bacteria groups in your product. The large number of scientific publications and clinical studies indicate that Lactobacillus (LA-5®), in combination with Bifidobacterium (BB-12®), may have beneficial gastrointestinal effects:

  • May reduce the duration of stomach upset2
  • May support the recolonization of the intestinal microbiota3

Nothing on this page is meant to be perceived as an approved claim.

Your opportunities

We offer Lactobacillus acidophilus (LA-5®) for dietary supplements and fermented milk products. Please contact us for more information about the probiotic strain.

As of July 2015
Chatterjee et al. 2013; de Vrese et al. 2011
Nord et al. 1997

Share this with: